The $647 bln group is hiking British obesity jab prices by 170%, a likely response to Donald Trump’s gripes over cheap ...

Mounjaro manufacturer Eli Lilly said it was raising the price by up to 170% which could hit people paying privately for the drug.

The survey of 2,000 weight loss patients found that a doubling in price would see 80% coming off Mounjaro, with 51% switching ...

New Mounjaro rules are set to kick in from September with prices skyrocketing by a staggering and eye-watering 170 per cent.

Eli Lilly is poised to dramatically increase the UK price of its weight-loss and diabetes drug Mounjaro, with certain dosages ...

Eli Lilly will raise UK private prices for Mounjaro by up to 170 percent from September 2025, with the highest dose set to ...

As results season winds down, Dan Jones and team discuss a property group’s results, alternative ways to find bargain stocks and Novo Nordisk vs Eli Lilly ...

Eli Lilly and Co (NYSE: LLY) has entered into a $1.3 billion deal with Superluminal Medicines to develop small-molecule drugs ...

Down here, I begin to think that we are too negative on it, but I am very upset with Lilly in the way they handled this, and ...

The injection was initially licensed to treat type 2 diabetes, but is now also prescribed to help with weight loss ...

Eli Lilly is to raise the UK list price of its weight-loss and type 2 diabetes treatment Mounjaro by up to 170pc to be in line with other European markets, it has said, as the pharma industry responds ...

At least 500,000 people in the UK take either Mounjaro or Wegovy, another weight-loss jab, through private prescriptions ...